Sackeim HA - Search Results

1

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease.

Prohovnik I, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO. Prohovnik I, et al. Among authors: sackeim ha. Neurology. 1988 Jun;38(6):931-7. doi: 10.1212/wnl.38.6.931. Neurology. 1988. PMID: 3368076

2

Behavioral syndromes in Alzheimer's disease.

Devanand DP, Brockington CD, Moody BJ, Brown RP, Mayeux R, Endicott J, Sackeim HA. Devanand DP, et al. Among authors: sackeim ha. Int Psychogeriatr. 1992;4 Suppl 2:161-84. Int Psychogeriatr. 1992. PMID: 1288661

3

Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study.

Devanand DP, Cooper T, Sackeim HA, Taurke E, Mayeux R. Devanand DP, et al. Among authors: sackeim ha. Psychopharmacol Bull. 1992;28(2):169-73. Psychopharmacol Bull. 1992. PMID: 1513920 Clinical Trial.

4

Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest.

Sackeim HA, Prohovnik I, Moeller JR, Brown RP, Apter S, Prudic J, Devanand DP, Mukherjee S. Sackeim HA, et al. Arch Gen Psychiatry. 1990 Jan;47(1):60-70. doi: 10.1001/archpsyc.1990.01810130062009. Arch Gen Psychiatry. 1990. PMID: 2294857

5

Dissociated effects of amphetamine on arousal and cortical blood flow in humans.

Kahn DA, Prohovnik I, Lucas LR, Sackeim HA. Kahn DA, et al. Among authors: sackeim ha. Biol Psychiatry. 1989 Mar 15;25(6):755-67. doi: 10.1016/0006-3223(89)90247-3. Biol Psychiatry. 1989. PMID: 2647156 Free article. Clinical Trial.

6

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

Devanand DP, Sackeim HA, Brown RP, Mayeux R. Devanand DP, et al. Among authors: sackeim ha. Arch Neurol. 1989 Aug;46(8):854-7. doi: 10.1001/archneur.1989.00520440036018. Arch Neurol. 1989. PMID: 2667504 Clinical Trial.

7

Psychosis, behavioral disturbance, and the use of neuroleptics in dementia.

Devanand DP, Sackeim HA, Mayeux R. Devanand DP, et al. Among authors: sackeim ha. Compr Psychiatry. 1988 Jul-Aug;29(4):387-401. doi: 10.1016/0010-440x(88)90020-x. Compr Psychiatry. 1988. PMID: 2900712 Review.

8

Gray-matter degeneration in presenile Alzheimer's disease.

Prohovnik I, Smith G, Sackeim HA, Mayeux R, Stern Y. Prohovnik I, et al. Among authors: sackeim ha. Ann Neurol. 1989 Feb;25(2):117-24. doi: 10.1002/ana.410250203. Ann Neurol. 1989. PMID: 2919865

9

Dosage, seizure threshold, and the antidepressant efficacy of electroconvulsive therapy.

Sackeim HA, Decina P, Prohovnik I, Portnoy S, Kanzler M, Malitz S. Sackeim HA, et al. Ann N Y Acad Sci. 1986;462:398-410. doi: 10.1111/j.1749-6632.1986.tb51274.x. Ann N Y Acad Sci. 1986. PMID: 3085569 Review. No abstract available.

10

Acute reductions of regional cerebral blood flow following electroconvulsive therapy. Interactions with modality and time.

Prohovnik I, Sackeim HA, Decina P, Malitz S. Prohovnik I, et al. Among authors: sackeim ha. Ann N Y Acad Sci. 1986;462:249-62. doi: 10.1111/j.1749-6632.1986.tb51259.x. Ann N Y Acad Sci. 1986. PMID: 3458407 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters